Versuchen GOLD - Frei

Religare independent directors in favour of Burmans' open offer

Mint New Delhi

|

January 14, 2025

The RBI, which has oversight on Religare Finvest, on 9 December approved the Burman acquisition

- Ranjani Raghavan & Nehal Chaliawala

Independent directors of Religare Enterprises Ltd are in favour of the proposed takeover by the Burman family, one of these directors said, reversing their previous opposition to the plan.

The change in stance comes after India's banking, pension and insurance regulators have given their go-ahead to the family's plans to launch an open offer for the financial conglomerate.

"Once the Reserve Bank of India (RBI) has given its approval, we must follow its directions," Religare independent director Malay Kumar Sinha said. "There is no one among the (independent) directors, who is against the directions of RBI and the Sebi (Securities and Exchange Board of India) order, on annual general meeting (AGM) or open offer," he said, adding that there is no difference in opinion among the independent directors on this matter.

Apart from Sinha, the board of Religare has five members, including executive chairperson Rashmi Saluja, and independent directors Ranjan Dwivedi, Hamid Ahmed, Preeti Madan and Praveen Kumar Tripathi.

WEITERE GESCHICHTEN VON Mint New Delhi

Mint New Delhi

Mint New Delhi

How CCI plans to watch AI use by companies

The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.

time to read

2 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY

The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.

time to read

3 mins

October 08, 2025

Mint New Delhi

US TARIFF-LED RISKS PERSIST FOR INDIA

The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.

time to read

3 mins

October 08, 2025

Mint New Delhi

Nykaa fashion arm sashays again—spotlight on the stride

The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.

time to read

1 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

‘RBI focusing on new use cases for e-rupee’

The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.

time to read

1 mins

October 08, 2025

Mint New Delhi

Nobel physics prize goes to pioneers of quantum mechanics

US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.

time to read

1 min

October 08, 2025

Mint New Delhi

Nvidia to continue sponsoring H-1B visas

Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.

time to read

1 min

October 08, 2025

Mint New Delhi

AstraZeneca to sell cancer drug in India

AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.

time to read

1 min

October 08, 2025

Mint New Delhi

Fintech lending growth slows after clampdown

But delinquency and deep-stage stress are still elevated, shows report

time to read

2 mins

October 08, 2025

Mint New Delhi

CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY

The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.

time to read

1 mins

October 08, 2025

Listen

Translate

Share

-
+

Change font size